CRIPGBM
CRIPGBM, a proapoptotic derivative of RIPGBM, a cell type-selective inducer of apoptosis in GBM cancer stem cells (CSCs) by binding to receptor-interacting protein kinase 2 (RIPK2), with an EC50 of 68 nM in GBM-1 cells[1].
Product Specifications
CAS Number
2361988-76-1
UNSPSC
12352005
Target
Apoptosis; Caspase; RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cRIPGBM.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C2[N+](CC3=CC=C(F)C=C3)=C(C)N1CC4=CC=CC=C4)C5=C(C=CC=C5)C2=O
Molecular Formula
C26H20FN2O2+
Molecular Weight
411.45
References & Citations
[1]Lucki NC, et al. A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer. Proc Natl Acad Sci U S A. 2019 Mar 26;116 (13) :6435-6440.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 1; RIPK2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7024085-01 0.02 mg
Recombinant Mycobacterium sp. NADH-quinone oxidoreductase subunit K (nuoK)
Sign In for Pricing
View Details MBS7024085-02 0.1 mg
Recombinant Mycobacterium sp. NADH-quinone oxidoreductase subunit K (nuoK)
Sign In for Pricing
View Details MBS7024085-03 5x 0.1 mg
Recombinant Mycobacterium sp. NADH-quinone oxidoreductase subunit K (nuoK)
Sign In for Pricing
View Details